The 4G/5G-polymorphism in the PAI-1 gene is not associated with markers of atherosclerosis in male smokers
- 1 August 2002
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 107 (3-4) , 115-119
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Genetic Variation in Coagulation and Fibrinolytic Proteins and Their Relation With Acute Myocardial InfarctionCirculation, 2001
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000
- Determinants of Plasma Levels of Plasminogen Activator Inhibitor-1Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
- The 4G4G Genotype of the Plasminogen Activator Inhibitor 4G/5G Gene Polymorphism Is Associated with Coronary Atherosclerosis in Patients at High Risk for this DiseaseThrombosis and Haemostasis, 1999
- PAI-1 Plasma Levels in a General Population Without Clinical Evidence of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- 4G/5G Promoter PAI-1 Gene Polymorphism Is Associated with Plasmatic PAI-1 Activity in Italians: A Model of Gene-Environment InteractionThrombosis and Haemostasis, 1998
- Fibrinogen, Plasminogen Activator Inhibitor-1, and Carotid Intima-Media Wall Thickness in the NHLBI Family Heart StudyThrombosis and Haemostasis, 1998
- The 4G/5G Polymorphism of PAI-1 Promoter Gene and the Risk of Myocardial Infarction: A Meta-analysisThrombosis and Haemostasis, 1998
- Five Frequent Polymorphisms of the PAI-1 GeneArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.Proceedings of the National Academy of Sciences, 1995